Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion type Assertion NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_head.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion wasGeneratedBy ECO_0000203 NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_provenance.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion wasDerivedFrom befree-2016 NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_provenance.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion SIO_000772 14531535 NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_provenance.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion evidence source_evidence_literature NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_provenance.
- NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_assertion description "[In a cross-sectional study we investigated relationships between the clinical outcome and Aza dose, the TPMT genotype and the Aza metabolite levels among patients with Crohn disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416016.RAMzb46x1RIQbV_u-xrPaOdygMrGTpgOL2sfBeZXRHrms130_provenance.